An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US med. app.

By: Cobbs C, McClay E, Duic JP, Nabors LB, Morgan DM, Kesari S
Published in: CNS Oncol 2019; 8 (1): CNS30
Download citation in RIS format

Exposure